COMPASS Pathways (CMPS) Stock Forecast, Price Target & Predictions
CMPS Stock Forecast
COMPASS Pathways stock forecast is as follows: an average price target of $23.00 (represents a 416.85% upside from CMPS’s last price of $4.45) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
CMPS Price Target
The average price target for COMPASS Pathways (CMPS) is $23.00 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $23.00 to $23.00. This represents a potential 416.85% upside from CMPS's last price of $4.45.
CMPS Analyst Ratings
According to 5 Wall Street analysts, COMPASS Pathways's rating consensus is 'Buy'. The analyst rating breakdown for CMPS stock is 0 'Strong Buy' (0.00%), 5 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
COMPASS Pathways Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 22, 2024 | Leonid Timashev | RBC Capital | - | - | 209.56% | 416.85% |
| Jun 05, 2024 | Vikram Purohit | Morgan Stanley | - | - | 243.29% | 416.85% |
The latest COMPASS Pathways stock forecast, released on Jul 22, 2024 by Leonid Timashev from RBC Capital, set a price target of $23.00, which represents a 209.56% increase from the stock price at the time of the forecast ($7.43), and a 416.85% increase from CMPS last price ($4.45).
COMPASS Pathways Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $23.00 |
| Last Closing Price | $4.45 | $4.45 | $4.45 |
| Upside/Downside | -100.00% | -100.00% | 416.85% |
In the current month, the average price target of COMPASS Pathways stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to COMPASS Pathways's last price of $4.45. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 11, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Nov 04, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Nov 01, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Jul 22, 2024 | RBC Capital | Outperform | Initialise | |
| Jun 05, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
| Apr 01, 2024 | Morgan Stanley | Overweight | Initialise | |
| Oct 13, 2022 | Oppenheimer | Outperform | Outperform | Hold |
COMPASS Pathways's last stock rating was published by Canaccord Genuity on Nov 11, 2024. The company gave CMPS a "Buy" rating, the same as its previous rate.
COMPASS Pathways Financial Forecast
COMPASS Pathways Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - |
| # Analysts | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - |
COMPASS Pathways's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. CMPS's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
COMPASS Pathways EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - |
undefined analysts predict CMPS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than COMPASS Pathways's previous annual EBITDA (undefined) of $NaN.
COMPASS Pathways Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - |
| Avg Forecast | $-32.68M | $-33.11M | $-37.09M | $-38.21M | $-42.82M | $-39.00M | $-36.83M |
| High Forecast | $-32.68M | $-33.11M | $-37.09M | $-37.47M | $-38.74M | $-39.00M | $-36.83M |
| Low Forecast | $-32.68M | $-33.11M | $-37.09M | $-38.21M | $-48.25M | $-39.00M | $-36.83M |
| Surprise % | - | - | - | - | - | - | - |
COMPASS Pathways's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CMPS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
COMPASS Pathways SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - |
COMPASS Pathways's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to CMPS last annual SG&A of $NaN (undefined).
COMPASS Pathways EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - |
| Avg Forecast | $-0.48 | $-0.48 | $-0.54 | $-0.56 | $-0.63 | $-0.57 | $-0.54 |
| High Forecast | $-0.48 | $-0.48 | $-0.54 | $-0.55 | $-0.57 | $-0.57 | $-0.54 |
| Low Forecast | $-0.48 | $-0.48 | $-0.54 | $-0.56 | $-0.71 | $-0.57 | $-0.54 |
| Surprise % | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, COMPASS Pathways's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CMPS previous annual EPS of $NaN (undefined).
COMPASS Pathways Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CMPS | COMPASS Pathways | - | - | 416.85% | Buy |
| AGL | agilon health | - | - | 147.19% | Buy |
| ACHC | Acadia Healthcare Company | - | - | 113.35% | Buy |
| CCRN | Cross Country Healthcare | - | - | 102.31% | Buy |
| SGRY | Surgery Partners | - | - | 74.73% | Buy |
| AMED | Amedisys | - | - | 59.03% | Hold |
| INNV | InnovAge | - | - | 46.87% | Hold |
| EHAB | Enhabit | - | - | 37.22% | Hold |
| PNTG | Pennant Group | - | - | 13.67% | Buy |
| ADUS | Addus HomeCare | - | - | 9.90% | Buy |
| ENSG | Ensign Group | - | - | 0.58% | Buy |
| DVA | DaVita | - | - | -23.54% | Hold |